查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1528121

世界人造器官市場

Artificial Organs
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 288 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，美國的全球人造器官市場將達到 432 億美元

2023年全球人造器官市場估計為260億美元，預計到2030年將達到432億美元，2023-2030年分析期間複合年成長率為7.5%。人工腎臟是本報告分析的細分市場之一，預計複合年成長率為 8.1%，到分析期結束時將達到 231 億美元。分析期間，人工胰臟細分市場的複合年成長率預計為 7.1%。

美國市場預計69億美元，中國預計複合年成長率7.0%

預計 2023 年美國人造器官市場規模將達 69 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達67億美元，2023-2030年分析期間複合年成長率為7.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.8% 和 6.2%。在歐洲，德國預計複合年成長率為 5.7%。

全球人造器官市場 - 主要趨勢和促進因素總結

仿生人：仍然是想像中的虛構人物，但正在緩慢而堅定地接近

想像一個仿生人走在我們中間的世界，不僅出現在科幻電影的閃爍畫面中，也成為我們日常生活現實的一部分。每當人造心臟跳動和人造肺部呼吸時，這現代科學奇蹟都反映了人類生物學的複雜交響曲。這個「人造器官」曾經只是他實驗室白板上的草圖，現在卻在他體內充滿了生命。他的血管裡流動著實驗室培養的血液，他的眼睛清晰可見，只有高清攝影機才能提供，他的指尖被設計成模仿人類皮膚的柔軟度，可以輕輕地觸摸。人工器官科學正在透過奇蹟般的創新將這個夢想變成現實。

什麼是人造器官？

人工器官是一種仿生裝置，植入或整合到人體中，以取代故障的自然器官，恢復特定功能或功能集，使患者恢復正常生活。這些包括人造心臟、人造腎臟、人造肝臟以及最近的生物人造胰臟和人造血管。人造器官的開發是一個複雜的多學科領域，結合了生物醫學工程、材料科學和細胞生物學的進步。此類設備的整合可以顯著改善器官衰竭患者的生活品質並延長其壽命。鑑於全球器官捐贈者短缺以及與糖尿病和心臟病等慢性疾病相關的器官衰竭發生率不斷增加，這一點尤其重要。

科技如何推進人造器官的功能？

技術進步是人工器官發展演化的核心。現代人造器官擴大採用先進的生物材料，這些材料具有生物相容性並且能夠執行複雜的生物功能。例如，在心臟瓣膜和血管中使用先進的聚合物和複合材料可以模仿人體組織的自然彈性和強度，降低血栓的風險並延長壽命。此外，3D生物列印的發展正在突破器官替代可能性的界限，使得列印複雜的組織和器官結構成為可能。這些技術不僅提高了人造器官的性能，還降低了排斥反應和其他與移植相關的併發症的併發症。

人造器官在醫學領域面臨哪些挑戰？

儘管取得了重大進展，但將人造器官融入醫學仍面臨一些挑戰。其中最主要的是身體排斥異物的傾向，這可能導致嚴重的併發症和設備故障。這需要持續服用藥物來抑制免疫系統，從而帶來長期的健康風險。此外，人造器官的耐用性和功能可能與天然器官不完全匹配，這會影響患者的生活品質。此外，開發和實施的高昂成本使得這些技術對於許多需要它們的人來說遙不可及。此外，必須克服道德和監管障礙，以確保新設備安全有效。應對這些挑戰需要持續的研究和創新，以及能夠跟上技術進步的全面法律規範。

推動人造器官市場成長的因素有哪些？

人造器官市場的成長受到多種因素的推動，包括提高這些設備的有效性和安全性的技術創新。糖尿病和心臟病等導致器官衰竭的慢性疾病的盛行率不斷上升，推動了世界各地對人造器官的需求。這是因為已開發國家的人口正在老化，老年人更有可能患上需要器官置換的疾病。此外，醫療基礎設施的改善和全球醫療支出的增加使更多人更容易獲得這些先進的治療方法。新興市場的經濟發展正進一步擴大人造器官市場範圍，提供新的就業機會。最後，器官捐贈可用性的持續挑戰繼續推動對替代解決方案的需求，並推動人造器官產業的成長，以滿足世界各地患者的關鍵需求。

受訪企業範例（71家知名企業）

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP-1126

Global Artificial Organs Market to Reach US$43.2 Billion by 2030

The global market for Artificial Organs estimated at US$26.0 Billion in the year 2023, is expected to reach US$43.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Artificial Kidneys, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$23.1 Billion by the end of the analysis period. Growth in the Artificial Pancreas segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 7.0% CAGR

The Artificial Organs market in the U.S. is estimated at US$6.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Artificial Organs Market - Key Trends and Drivers Summarized

The Bionic Man: Still a Figment of Our Imagination, but We Are Getting There Slowly and Decisively

Imagine a world where the bionic man walks among us, not just in the flickering frames of a sci-fi film but as a part of our everyday reality. With each beat of his engineered heart and each breath drawn by synthetic lungs, this marvel of modern science mirrors the intricate symphony of human biology. Artificial organs, once mere sketches on research lab whiteboards, now pulse with life within him. His veins course with lab-crafted blood, his eyes see with the clarity only high-definition cameras can provide, and his touch is gentle with fingers engineered to mimic the softness of human skin. While the true incarnation of the bionic man remains nestled in the realm of future possibilities, the science of artificial organs is knitting this dream into the fabric of the probable, one miraculous innovation at a time.

What Are Artificial Organs, and How Are They Changing Lives?

Artificial organs are bioengineered devices that are implanted or integrated into human bodies to replace natural organs that have failed, restoring a specific function or a group of related functions to help the patient return to a normal life. These include artificial hearts, kidneys, livers, and more recently, bioartificial pancreases and synthetic blood vessels. The development of artificial organs is a complex, interdisciplinary field that combines advancements in biomedical engineering, materials science, and cellular biology. The integration of such devices can significantly improve the quality of life and extend the lifespan of individuals suffering from organ failure. This is especially critical given the global shortage of organ donors and the increasing incidence of organ failure linked to chronic diseases such as diabetes and heart disease.

How Is Technology Advancing the Functionality of Artificial Organs?

Technological advancements are at the core of the evolution in artificial organ development. Modern artificial organs are increasingly incorporating advanced biomaterials that are biocompatible and can perform complex biological functions. For instance, the use of cutting-edge polymers and composite materials in heart valves and blood vessels can mimic the natural elasticity and strength of human tissue, reducing the risk of blood clots and improving longevity. In addition, developments in 3D bioprinting are pushing the boundaries of what's possible in organ replacement, allowing for the printing of complex tissues and organ structures that could one day lead to fully functional, biologically active organs. These technologies not only enhance the performance of artificial organs but also reduce the risk of rejection and other complications associated with transplants.

What Challenges Do Artificial Organs Face in Medical Practice?

Despite significant advancements, the integration of artificial organs into medical practice faces several challenges. The foremost is the body's tendency to reject foreign objects, which can lead to serious complications or device failure. This necessitates ongoing medication regimes to suppress the immune system, posing long-term health risks. Additionally, the durability and functionality of artificial organs may not fully match those of their natural counterparts, which can affect the patient's quality of life. There is also the high cost of development and implementation, making these technologies inaccessible to many who need them. Furthermore, ethical and regulatory hurdles must be navigated to ensure that new devices are both safe and effective. Addressing these challenges requires continuous research and innovation, as well as comprehensive regulatory frameworks that can keep pace with technological advancement.

What Drives the Growth in the Artificial Organs Market?

The growth in the artificial organs market is driven by several factors, including technological innovations that enhance the effectiveness and safety of these devices. The rising prevalence of chronic diseases that lead to organ failure, such as diabetes and heart disease, is increasing the demand for artificial organs worldwide. Aging populations in developed countries also contribute to this demand, as older age groups are more likely to suffer from conditions requiring organ replacement. Additionally, improvements in healthcare infrastructure and increased healthcare spending globally make these advanced treatments more accessible to a broader audience. Economic development in emerging markets further expands the reach of the artificial organs market, providing new opportunities for adoption. Lastly, the ongoing challenges in donor organ availability continue to push the need for alternative solutions, bolstering the growth of the artificial organs industry as it works to meet the critical needs of patients worldwide.

Select Competitors (Total 71 Featured) -

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Artificial Organs - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Breakthroughs in Biomaterials and Biocompatibility Expand Market Opportunities
    • Rising Incidence of Organ Failure and Limitations in Donor Availability Propel Demand
    • Advances in 3D Printing and Bioprinting Technologies Strengthen Market Potential
    • Growth in Healthcare Expenditure and Investments in Advanced Medical Technologies
    • Innovations in Artificial Heart and Kidney Devices Set the Stage for Growth
    • Ethical and Moral Challenges Impacting the Adoption of Artificial Organs
    • Technological Convergence in Robotics, Nanotechnology, and Biomedicine
    • Advances in Sensory and Feedback Technologies for Prosthetics and Implants
    • Innovations in Immunosuppression and Post-transplant Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Organs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Artificial Kidneys by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Artificial Pancreas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Artificial Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Artificial Lungs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • JAPAN
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • CHINA
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • EUROPE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • FRANCE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • GERMANY
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of World 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030

IV. COMPETITION